|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/46 | (2006.01) |
| A61K 38/51 | (2006.01) | ||
| A61K 35/18 | (2015.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3397272 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17700008.0 |
| Europos patento paraiškos padavimo data | 2017-01-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/050006 |
| Data | 2017-01-02 |
| (87) | Numeris | WO 2017/114966 |
| Data | 2017-07-06 |
| (30) | Numeris | Data | Šalis |
| 15307197 | 2015-12-31 | EP |
| (72) |
AGUERA, Karine , FR
BERLIER, Willy , FR
GAY, Fabien , FR
GODFRIN, Yann , FR
|
| (73) |
Erytech Pharma ,
60 Avenue Rockefeller, 69008 Lyon,
FR
|
| (54) | METHIONINE AND ASPARAGINE DEPLETION FOR USE IN TREATING A CANCER |
| METHIONINE AND ASPARAGINE DEPLETION FOR USE IN TREATING A CANCER |